Significantly Lower Serum Adiponectin Levels in the Postmenopausal Age may be Specific for Breast Cancer Risk


AKSOY T. , Trabulus D. C. , Aral H., Serin E., Talu C. K.

ISTANBUL MEDICAL JOURNAL, cilt.21, sa.5, ss.355-361, 2020 (ESCI İndekslerine Giren Dergi) identifier

  • Cilt numarası: 21 Konu: 5
  • Basım Tarihi: 2020
  • Doi Numarası: 10.4274/imj.galenos.2020.92979
  • Dergi Adı: ISTANBUL MEDICAL JOURNAL
  • Sayfa Sayıları: ss.355-361

Özet

Introduction: To date, biomarkers have played a minimal role in the early diagnosis of breast cancer. Although its effects on metabolism are not well known, studies have shown that hypoadiponectinaemia is associated with increased insulin resistance and risk for type-2 diabetes. We aimed to investigate the value of adiponectin together with laboratory results, anthropometric measurements and histopathological findings in assessing the risk of breast cancer and for use in early diagnosis.